American Well's (AMWL) "Sell (E+)" Rating Reaffirmed at Weiss Ratings

Key Points

• American Well's stock received a reaffirmed "sell (e+)" rating from Weiss Ratings, indicating continued negative sentiment from analysts.
• Wells Fargo & Company has reduced its price target for American Well from $15.00 to $12.00, while the stock has a consensus rating of "Hold" and an average price target of $9.17.
• American Well reported better-than-expected quarterly earnings with a loss of ($1.24) EPS, outperforming the consensus estimate by $0.60.

American Well (NYSE:AMWL - Get Free Report)'s stock had its "sell (e+)" rating restated by investment analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Separately, Wells Fargo & Company decreased their price target on American Well from $15.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $9.17.

American Well Price Performance

AMWL traded up $0.20 during midday trading on Wednesday, hitting $6.24. 103,063 shares of the company's stock traded hands, compared to its average volume of 60,971. The company has a market cap of $100.78 million, a PE ratio of -0.77 and a beta of 1.26. American Well has a one year low of $5.98 and a one year high of $12.95. The stock's fifty day simple moving average is $6.82 and its 200-day simple moving average is $7.25.

American Well (NYSE:AMWL - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported ($1.24) EPS for the quarter, topping the consensus estimate of ($1.84) by $0.60. American Well had a negative net margin of 46.15% and a negative return on equity of 41.99%. The company had revenue of $70.90 million for the quarter, compared to analyst estimates of $63.87 million. American Well has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts expect that American Well will post -9.34 EPS for the current year.

Insider Buying and Selling at American Well

In related news, insider Phyllis Gotlib sold 4,959 shares of the business's stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $6.11, for a total transaction of $30,299.49. Following the transaction, the insider directly owned 127,151 shares in the company, valued at $776,892.61. The trade was a 3.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Deborah C. Jackson sold 4,531 shares of the firm's stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $6.56, for a total value of $29,723.36. Following the completion of the sale, the director owned 39,132 shares of the company's stock, valued at $256,705.92. This represents a 10.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 49,383 shares of company stock valued at $331,514 in the last ninety days. Company insiders own 12.80% of the company's stock.

Institutional Investors Weigh In On American Well

Several institutional investors and hedge funds have recently bought and sold shares of AMWL. JPMorgan Chase & Co. lifted its holdings in shares of American Well by 16.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company's stock worth $131,000 after acquiring an additional 2,081 shares during the period. Two Sigma Investments LP lifted its stake in American Well by 12.3% during the fourth quarter. Two Sigma Investments LP now owns 19,216 shares of the company's stock worth $139,000 after purchasing an additional 2,102 shares during the period. Headlands Technologies LLC acquired a new stake in American Well during the second quarter valued at approximately $39,000. Senvest Management LLC boosted its holdings in American Well by 0.3% during the second quarter. Senvest Management LLC now owns 1,312,852 shares of the company's stock valued at $11,671,000 after purchasing an additional 4,497 shares in the last quarter. Finally, Sapient Capital LLC bought a new stake in shares of American Well in the 1st quarter valued at approximately $79,000. Institutional investors own 56.05% of the company's stock.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.